Can introduction of palliative care limit ICU, emergency and hospital admissions in severe COPD?

Conclusion: In this pilot study, EPPC did not impact on the predefined outcomes. Possible explanations:number of cases and degree of care already provided
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Rehabilitation and Chronic Care Source Type: research

Related Links:

Conclusion: This study emphasizes the impact of comorbidities and its real burden in COPD. For better outcomes and quality of life each comorbidity should be individually assessed and treated
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Clinical Problems Source Type: research
Background: Personalised therapy for COPD patients is debated. We investigated whether the rate of FEV1 decline differs between patients with and without ICS-containing medications, stratified by blood EOS level.Methods: The UK Clinical Practice Research Datalink (primary care records) and Hospital Episode Statistics (hospital records) were used to identify COPD patients with ≥2 FEV1 measurements ≥6 months apart. Follow-up started from first FEV1 until censoring at death, leaving database or first ICS-containing prescription (if not baseline ICS-containing user). The nearest blood EOS 2 years prior to the start of fo...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Epidemiology Source Type: research
This study aimed to generate real-world evidence to assess the burden of comorbidities in COPD patients, to effectively manage these patients and optimize the associated healthcare resource allocation. ARCTIC is a large, real-world, retrospective cohort study conducted in Swedish COPD patients using electronic medical record data collected between 2000 and 2014. These patients were studied for prevalence of various comorbidities and for association of these comorbidities with exacerbations, mortality, and healthcare costs compared with an age-, sex-, and comorbidities-matched non-COPD reference population. A total of 17,47...
Source: Primary Care - Category: Primary Care Authors: Tags: NPJ Prim Care Respir Med Source Type: research
It is estimated that>85% of patients with chronic obstructive pulmonary disease (COPD) have ≥1 coexisting chronic condition.1 Co-morbidities commonly associated with COPD include cardiovascular disease, osteoporosis, lung cancer, diabetes, metabolic syndrome, depression/anxiety, and fatigue.2 Co-morbidities can have a profound effect on quality of life (QoL) for patients with COPD and ha ve been shown to increase severity of symptoms such as dyspnea and exacerbations, as well as further reducing exercise capacity.
Source: The American Journal of Medicine - Category: General Medicine Authors: Source Type: research
Conclusion: A 7 weeks / 20 sessions outpatient PR program have significant positive impact in terms of quality of life, exercise tolerance, dyspnea and psychological status in patients with COPD and lung resection for cancer.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Rehabilitation and Chronic Care Source Type: research
Conclusions Our results confirm that SABR is well tolerated and does not have a deleterious effect on QoL and psychological state. Results of our study indicate the importance of additional psychological care in the group of patients with COPD.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research
AbstractSupportive care and pharmacological treatment can improve the quality of life of people with end-stage chronic obstructive pulmonary disease (COPD) who cope on a daily basis with substantial physical, psychological, social and spiritual morbidity. Smoking cessation is the only intervention that reduces the rate of progression of COPD, but evidence-based drug treatments and non-pharmacological strategies can relieve symptoms and reduce the impact of exacerbations. People with severe COPD live with increasingly troublesome breathlessness and other symptoms such as fatigue, pain, sputum production and weight loss. As ...
Source: Drugs and Aging - Category: Geriatrics Source Type: research
Conclusion: Comorbid disease was frequently recorded in this asthma population. All-cause mortality for the study population did not differ from the Swedish population overall, but a higher death rate due to pulmonary causes (mainly COPD) was seen among the asthma patients.Sponsor: AstraZeneca.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: 1.6 General Practice and Primary Care Source Type: research
Conclusions: The prevalence of comorbidities in patients with stable COPD was high. Mortality in these patients is related to the number of comorbidities and anxiolytic treatment. Mortality was higher in patients with 2 o more comorbidities.Funded by NEUMOSUR.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: 5.2 Monitoring Airway Disease Source Type: research
Authors: Garvey C Abstract Chronic obstructive pulmonary disease (COPD), characterized by chronic airways inflammation and progressive airflow limitation, is a common, preventable and treatable disease. Worldwide, COPD is a major cause of morbidity and mortality; smoking tobacco is the most important risk factor. This translational review of recent updates in COPD care for the primary care audience, includes recommendations from the 2015 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report on diagnosis, pharmacological and non-pharmacological treatment, prevalence of comorbidities, management of exa...
Source: Postgraduate Medicine - Category: Internal Medicine Tags: Postgrad Med Source Type: research
More News: Anxiety | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | Depression | Emergency Medicine | Lung Cancer | Palliative | Palliative Care | Rehabilitation | Respiratory Medicine | Smokers | Study